---
title: 'Elevated level of lysophosphatidic acid among patients with HNF1B mutations
  and its role in RCAD syndrome: a multiomic study'
date: '2022-02-18'
linkTitle: http://link.springer.com/10.1007/s11306-022-01873-z
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">Patients
  with hepatocyte nuclear factor-1 beta (<em class="a-plus-plus">HNF1B</em>) mutations
  present a variable phenotype with two main symptoms: maturity onset diabetes of
  the young (MODY) and polycystic kidney disease (PKD).</p> </span> <span class="a-plus-plus
  abstract-section id-a-sec2"> <h3 class="a-plus-plus">Objectives</h3> <p class="a-plus-plus">Identification
  of serum metabolites specific for <em class="a-plus-plus">HNF1B</em>mu ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">Patients with hepatocyte nuclear factor-1 beta (<em class="a-plus-plus">HNF1B</em>) mutations present a variable phenotype with two main symptoms: maturity onset diabetes of the young (MODY) and polycystic kidney disease (PKD).</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Objectives</h3> <p class="a-plus-plus">Identification of serum metabolites specific for <em class="a-plus-plus">HNF1B</em>mu ...